Projecten per jaar
Persoonlijk profiel
Expertise
Prof Dr Tony Lahoutte is head of the department of nuclear medicine at UZ Brussel and head of the molecular imaging research unit at the Vrije Universiteit Brussel (VUB) in Belgium. In 2014 he co-founded the company Camel-IDS NV that is developing a pipeline of radio-immuno therapeutics where he is CSO. He obtained his medical degree in 1998 and started his research activities in combination with a residency program in nuclear medicine. His current research is focused on the development and clinical translation of molecular imaging probes and targeted radionuclide therapies for the detection and treatment of cancer.
Vingerafdruk
Verdiep u in de onderzoeksgebieden waarop Tony Lahoutte actief is. Deze onderwerplabels komen uit het werk van deze persoon. Samen vormen ze een unieke vingerafdruk.
- 1 Soortgelijke profielen
Samenwerkingen en hoofdonderzoeksgebieden uit de afgelopen vijf jaar
Recente externe samenwerking op landen-/regioniveau. Duik in de details door op de stippen te klikken of
-
ANI437: Understanding tumour biology and microenvironment: from Translational Research to Personalised Cancer Care with PET/CT
Lahoutte, T. (Administrative Promotor) & De Mey, L. (PI (Promotor, Principal Investigator))
1/10/25 → 30/09/26
Project: Fundamenteel
-
IOF3036: INTEGRAL - Integratie van een multimodale aanpak om de huidige uitdagingen in immuuntherapie aan te pakken
Van Ginderachter, J. (Administrative Promotor), Laoui, D. (CoI (Co-Promotor)), Movahedi, K. (CoI (Co-Promotor)), Hadadi, E. (CoI (Co-Promotor)), Stijlemans, B. (CoI (Co-Promotor)), Raes, G. (CoI (Co-Promotor)), Devoogdt, N. (CoI (Co-Promotor)), Lahoutte, T. (CoI (Co-Promotor)), De Groof, T. (CoI (Co-Promotor)), Goyvaerts, C. (CoI (Co-Promotor)), D'Huyvetter, M. (CoI (Co-Promotor)), Debacker, J. (CoI (Co-Promotor)), Breckpot, K. (CoI (Co-Promotor)), Franceschini, L. (CoI (Co-Promotor)), Raes, G. (Mandataris) & Revets, H. (Mandataris)
1/01/25 → 31/12/29
Project: Toegepast
-
OZR4192: Bilateral cooperation within the framework of a joint doctoral project: benchfee for joint PhD VUB - UC Louvain, DE MEY Lynn
Lahoutte, T. (Administrative Promotor)
18/09/23 → 30/09/27
Project: Fundamenteel
-
FWOIRI9: Flanders BioImaging: Toonaangevende geïntegreerde service en ondersteuning voor toegepaste biologische beeldvorming.
Lahoutte, T. (Administrative Promotor)
1/01/23 → 31/12/26
Project: Fundamenteel
-
SRP83: SRP-Onderzoekszwaartepunt: Immunoregulatoire cellen als doelwit voor moleculaire beeldvorming en therapie in inflammatoire ziekten en kanker
Van Ginderachter, J. (Administrative Promotor), Lahoutte, T. (CoI (Co-Promotor)), Lahoutte, T. (Administrative Promotor), Van Ginderachter, J. (Co-Promoter), Devoogdt, N. (Co-Promoter), Raes, G. (Medewerker), Stijlemans, B. (Medewerker), Vincke, C. (Medewerker) & De Groof, T. (Medewerker)
1/11/22 → 31/10/27
Project: Fundamenteel
Onderzoeksoutput
-
Alphavision: 12 points go to… Astatine-211
Raes, L., Sevenois, M., Bourgeois, S., Bracke, A., De Mey, L., Everaert, H. & Lahoutte, T., 8 feb. 2025.Onderzoeksoutput: Unpublished abstract
-
Efficient α and β- radionuclide therapy targeting fibroblast activation protein-α in an aggressive preclinical mouse tumour model
Ceuppens, H., Pombo Antunes, A. R., Navarro, L., Ertveldt, T., Berdal, M., Nagachinta, S., De Ridder, K., Lahoutte, T., Keyaerts, M., Devoogdt, N., Goyvaerts, C., D'Huyvetter, M. & Breckpot, K., jan. 2025, In: European Journal of Nuclear Medicine and Molecular Imaging. 52, 2, blz. 444-457 14 blz.Onderzoeksoutput: Article › peer review
Open AccessBestand7 Citaten (Scopus)9 Downloads (Pure) -
Immune modulation following α and β- radionuclide therapy targeting fibroblast activation protein-α in a preclinical tumor model
Ceuppens, H., De Ridder, K., Ertveldt, T., Zeven, K., de Mey, W., Pombo Antunes, A. R., Navarro, L., Dumauthioz, N., Lahoutte, T., Debacker, J., Devoogdt, N., Keyaerts, M., D'Huyvetter, M., Goyvaerts, C. & Breckpot, K., 1 dec. 2025, In: Oncoimmunology. 14, 1, 16 blz., 2540054.Onderzoeksoutput: Article › peer review
Open Access -
Preclinical synergistic effects when combining a radiolabelled HER2-targeting single domain antibody with PARP inhibitor Olaparib
Devoogdt, N., D'Huyvetter, M., Lahoutte, T., Dewulf, J., Navarro, L., Dumauthioz, N., Berdal, M., Nagachinta, S., Gaspariunaite, V., Pombo Antunes, A. R. & Massa, S., 13 dec. 2025, (Accepted/In press) In: Journal of Translational Medicine. 12 blz.Onderzoeksoutput: Article › peer review
Open Access -
[68Ga]Ga-NOTA-anti-HER2-VHH1PET/CT Imaging of brain metastasis: first clinical results in patients with HER2 positive and HER2 negative breast cancer.
De Mey, L., Gondry, O. (Redacteur), Bourgeois, S. (Redacteur), Bracke, A. (Redacteur), Everaert, H. (Redacteur), Goethals, L. (Redacteur), Raes, L. (Redacteur), Caveliers, V. (Redacteur), Van den Block, S. (Redacteur), Decoster, L. (Redacteur), Fontaine, C. (Redacteur), Devoogdt, N. (Redacteur), Dierick, H. (Redacteur), Cousaert, J. (Redacteur), Lahoutte, T. (Redacteur) & Keyaerts, M. (Redacteur), 2024.Onderzoeksoutput: Poster
Prijzen
-
Professor Roger Van Geen Award
Lahoutte, T. (Recipient), nov. 2014
Prijs: Prize (including medals and awards)
Activiteiten
-
Fully automated production of [18F]FB-labeled single-domain antibodies: the immune-checkpoint TIGIT for PET imaging
Dierick, H. (Speaker), Zeven, K. (Contributor), Navarro, L. (Contributor), Lahoutte, T. (Contributor), Devoogdt, N. (Contributor), Caveliers, V. (Contributor) & Bridoux, J. (Contributor)
18 apr. 2024 → 21 apr. 2024Activiteit: Talk or presentation at a conference
-
PET/CT imaging of high mannose receptor expressing macrophages: first clinical results in cancer and inflammatory disease
De Mey, L. (Speaker), Gondry, O. (Contributor), Bracke, A. (Contributor), Bourgeois, S. (Contributor), Everaert, H. (Contributor), Goethals, L. (Contributor), Raes, L. (Contributor), Gebruers, J. (Contributor), Waelput, W. (Contributor), Caveliers, V. (Contributor), Debacker, J. (Contributor), Devoogdt, N. (Contributor), Dierick, H. (Contributor), Cousaert, J. (Contributor), De Beule, N. (Contributor), Kerselaers, L. A. A. (Contributor), Keyaerts, M. (Contributor) & Lahoutte, T. (Contributor)
12 mrt. 2024Activiteit: Talk or presentation at a conference
-
PET/CT imaging with [68Ga]Ga-NOTA-anti-MMR-VHH2 in patients with NSCLC: Interim results of the MAGMA trial
De Mey, L. (Speaker), Bourgeois, S. (Contributor), Bracke, A. (Contributor), Everaert, H. (Contributor), Goethals, L. (Contributor), Gondry, O. (Contributor), Debacker, J. (Contributor), Keyaerts, M. (Contributor), Devoogdt, N. (Contributor), Forsyth, R. (Contributor), Locy, H. (Contributor), Raes, L. (Contributor), Caveliers, V. (Contributor), Van den Block, S. (Contributor), Vaneycken, I. (Contributor), Cousaert, J. (Contributor) & Lahoutte, T. (Contributor)
11 okt. 2024Activiteit: Talk or presentation at a conference
-
PET/CT imaging of high mannose receptor expressing macrophages with [68Ga]Ga-NOTA -Anti-MMR-VHH2: an overview of the clinical results
De Mey, L. (Speaker), Bourgeois, S. (Contributor), Bracke, A. (Contributor), Gondry, O. (Contributor), Everaert, H. (Contributor), Goethals, L. (Contributor), Debacker, J. (Contributor), Keyaerts, M. (Contributor), Devoogdt, N. (Contributor), Raes, L. (Contributor), Caveliers, V. (Contributor), Van den Block, S. (Contributor), Vaneycken, I. (Contributor), Cousaert, J. (Contributor), De Beule, N. (Contributor), Kerselaers, L. A. A. (Contributor), Forsyth, R. (Contributor), Locy, H. (Contributor) & Lahoutte, T. (Contributor)
11 okt. 2024Activiteit: Talk or presentation at a conference
-
PET/CT imaging with [68Ga]Ga-NOTA-anti-HER2-VHH1 in cancer patients with potential HER2 expression: first clinical results.
De Mey, L. (Speaker), Gondry, O. (Contributor), Bourgeois, S. (Contributor), Bracke, A. (Contributor), Everaert, H. (Contributor), Goethals, L. (Contributor), Raes, L. (Contributor), Caveliers, V. (Contributor), Van den Block, S. (Contributor), Joris, S. (Contributor), de Haar-Holleman, A. (Contributor), Fontaine, C. (Contributor), Devoogdt, N. (Contributor), Dierick, H. (Contributor), Cousaert, J. (Contributor), Lahoutte, T. (Contributor) & Keyaerts, M. (Contributor)
22 okt. 2024Activiteit: Talk or presentation at a conference
Knipsels
-
Camel blood to fight cancer? This VUB spin-off is getting amazing results
Lahoutte, T., Devoogdt, N., D'Huyvetter, M., De Vos, J. & Mebis, C.
17/11/17
1 Mediabijdrage
Pers / media: !!Research
-
Kanker bestrijden met elektrische fietsjes in het bloed
Lahoutte, T., Devenyns, R., Devoogdt, N., D'Huyvetter, M., De Vos, J. & Mebis, C.
17/10/17
1 Mediabijdrage
Pers / media: !!Research
-
-
Lama-antistoffen in strijd tegen kanker
Lahoutte, T., Devoogdt, N., D'Huyvetter, M., De Vos, J. & Mebis, C.
30/03/17
1 Mediabijdrage
Pers / media: !!Research
-
Toelichting in het kader van Google X: Ontwikkeling van nanopartikels als diagnostische tool bij kankerbestrijding
29/10/14
1 Mediabijdrage
Pers / media: !!Other
Scriptie
-
CAMEL-KIT: Single-step labeling of single-domain antibody fragments with 68Ga for PET imaging
Baudhuin, H. V. ((PhD) Student) & Lahoutte, T. ((PhD) Student), Xavier, C. (Promotor), 2021Scriptie/Masterproef: Doctoral Thesis
-
Development of a circulating tumor cell model in mice
Vandereycken, J. ((PhD) Student), Lahoutte, T. (Promotor), Goethals, L. (Co-promotor) & Keyaerts, M. (Jury), 10 jun. 2015Scriptie/Masterproef: Master's Thesis